Maarten Dewilde (M Dewilde)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Pharmaceutics

Advanced healthcare materials

Cancers

Fluids and barriers of the CNS

Vlaams Instituut voor Biotechnologie

KU Leuven (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vlaams Instituut voor Biotechnologie Oct 01 2017

Belgium

Expert Scienist Therapeutic Biologics

Vlaams Instituut voor Biotechnologie Sep 01 2014

Belgium

Staff Scientist

Ablynx nv Jun 01 2011 - Aug 31 2014

Belgium

Scientist Team Leader

Ablynx nv Oct 01 2008 - May 31 2011

Belgium

Associate Scientist

Education History

KU Leuven Oct 01 2003 - Sep 25 2008

Belgium

PHD

KU Leuven Oct 01 1998 - Jul 05 2003

Belgium

MSC

Publications

Simone Marcigaglia, Robin De Plus, Charysse Vandendriessche, Eleonore Schiltz, Marie-Lynn Cuypers, Jordi Cools, Luis D Hoffman, Roosmarijn E. Vandenbroucke, Maarten Dewilde, Sebastian Haesler
Microfluidic Interfaces for Chronic Bidirectional Access to the Brain. Advanced healthcare materials 13 (22) (2024)
Simone Marcigaglia, Robin De Plus, Charysse Vandendriessche, Eleonore Schiltz, Marie-Lynn Cuypers, Jordi Cools, Luis D Hoffman, Roosmarijn E. Vandenbroucke, Maarten Dewilde, Sebastian Haesler
Microfluidic Interfaces for Chronic Bidirectional Access to the Brain. Advanced healthcare materials (2024)
Simone Marcigaglia, Robin De Plus, Charysse Vandendriessche, Eleonore Schiltz, Marie-Lynn Cuypers, Jordi Cools, Luis D Hoffman, Roosmarijn E. Vandenbroucke, Maarten Dewilde, Sebastian Haesler
Microfluidic Interfaces for Chronic Bidirectional Access to the Brain. Advanced healthcare materials (2024)
Marie-Lynn Cuypers, Nick Geukens, Kevin Hollevoet, Paul J Declerck, Maarten Dewilde
Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice. Pharmaceutics 15 (4) (2023)
Marie-Lynn Cuypers, Nick Geukens, Kevin Hollevoet, Paul J Declerck, Maarten Dewilde
Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice. Pharmaceutics 15 (4) (2023)
Marie-Lynn Cuypers, Nick Geukens, Kevin Hollevoet, Paul J Declerck, Maarten Dewilde
Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice. Pharmaceutics 15 (4) (2023)
Laura Rué, Tom Jaspers, Isabelle M S Degors, Sam Noppen, Dominique Schols, Bart De Strooper, Maarten Dewilde
Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics. Pharmaceutics 15 (6) (2023)
Laura Rué, Tom Jaspers, Isabelle M S Degors, Sam Noppen, Dominique Schols, Bart De Strooper, Maarten Dewilde
Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics. Pharmaceutics 15 (6) (2023)
Marie-Lynn Cuypers, Nick Geukens, Kevin Hollevoet, Paul J Declerck, Maarten Dewilde
Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice. Pharmaceutics 15 (4) (2023)
Yannick De De Vlaeminck, Stefano Bonelli, Robin Maximilian Awad, Maarten Dewilde, Sabrina Rizzolio, Quentin Lecocq, Evangelia Bolli, Ana Rita Santos, Damya Laoui, Steve Schoonooghe, Luca Tamagnone, Cleo Goyvaerts, Massimiliano Mazzone, Karine Breckpot, Jo A Van Ginderachter
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development. Cancers 12 (12) (2020)
Y Wouters, T Jaspers, B De Strooper, Maarten Dewilde
Identification and in vivo characterization of a brain-penetrating nanobody. Fluids and barriers of the CNS 17 (1) (2020)

Maarten Dewilde.css-eqlu8i{font-size:small;padding-left:4px;} (M Dewilde)

Publication Activity (10 Years)

Top Topics

Top Venues

Maarten Dewilde (M Dewilde)